Neuromuscular Network News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Neuromuscular network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Neuromuscular Network Today - Breaking & Trending Today

Health Canada Authorizes EVRYSDI® (risdiplam) for the treatment of spinal muscular atrophy (SMA) in adults and children


iii
MISSISSAUGA, ON, April 15, 2021 /CNW/ - Hoffmann-La Roche Limited (Roche Canada) today announced that Health Canada has granted EVRYSDI
Ⓡ (risdiplam) market authorization for the treatment of spinal muscular atrophy (SMA) in patients two months of age or older.
iii
EVRYSDI works by helping the body make more of a protein called, SMN protein. EVRYSDI increases and sustains the amount of SMN protein in the body, which helps to treat SMA. It is the first medicine for SMA that can be taken at home and is administered once daily by mouth or feeding tube.
iii
The Health Canada approval of EVRYSDI is a welcome addition in our ability to treat SMA. It is an efficacious treatment that significantly increases survival motor neuron (SMN) protein in SMA patients, said Dr. Hugh McMillan, Pediatric Neurologist at the Children s Hospital of Eastern Ontario. We now have an additional and convenient treatment option with EVRYSDI, as it s the first at-home and ora ....

Hugh Mcmillan , Amy Loignon , Jennifer Mota , Neuromuscular Network , Roche Limited Canada , Toddler Development , Health Canada , Health Canada Approval , Roche Canada , Pediatric Neurologist , Bayley Scales , Third Edition , Motor Function , Spinal Muscular Atrophy , Diabetes Care , Muscular Atrophy , Media Contacts , Karley Ura , ஹக் மக்மிலந் , ஜெனிபர் மோட்டா , ரோச் வரையறுக்கப்பட்டவை கனடா , குறுநடை போடும் குழந்தை வளர்ச்சி , ஆரோக்கியம் கனடா , ஆரோக்கியம் கனடா ஒப்புதல் , ரோச் கனடா , குழந்தை நரம்பியல் நிபுணர் ,